[HTML][HTML] 新生儿期起病的罕见肝窦阻塞综合征1 例
王子鸣， 邓英平， 施元美， 王来栓， 孙松… - Chinese Journal of …, 2023 - ncbi.nlm.nih.gov
患儿， 男， 1 个月14 d， 因腹胀2 周， 加重3 d 入院。 患儿生后曾有脐炎病史，
体格检查示腹胀明显、 腹壁静脉显露、 肝脾触诊不满意， 移动性浊音阳性 …
体格检查示腹胀明显、 腹壁静脉显露、 肝脾触诊不满意， 移动性浊音阳性 …
Liver Pathology After Hematopoietic Stem Cell Transplantation
R Phansalkar, N Kambham… - Surgical Pathology …, 2023 - surgpath.theclinics.com
Hematopoietic stem cell transplantation is used to treat a variety of hematologic
malignancies and autoimmune conditions. The immunosuppressive medications as well as …
malignancies and autoimmune conditions. The immunosuppressive medications as well as …
[PDF][PDF] Early liver complications after allogeneic haematopoietic stem cell transplantation in patients with myelofibrosis: A study on behalf of the Chronic Malignancies …
M Robin, L Gras, L Koster, N Gagelmann… - British Journal of …, 2024 - orbi.uliege.be
Patients with myelofibrosis (MF) have established liver myeloid metaplasia and are more
susceptible to additional hepatic disorders such as fibrosis or vascular complications. 1–3 …
susceptible to additional hepatic disorders such as fibrosis or vascular complications. 1–3 …
Defibrotide prophylaxis for prevention of sinusoidal obstruction syndrome–Authors' reply
SA Grupp - The Lancet Haematology, 2023 - thelancet.com
25: 1271–80. 3 Hwang DY, Kim SJ, Cheong JW, et al. High pre-transplant serum ferritin and
busulfan-thiotepa conditioning regimen as risk factors for hepatic sinusoidal obstructive …
busulfan-thiotepa conditioning regimen as risk factors for hepatic sinusoidal obstructive …
[HTML][HTML] VOD/SOS and Alkylating agents in the hematopoietic stem cell transplant setting: new insights and further questions
AL Myers - … and Cellular Therapy, Official Publication of the …, 2022 - astctjournal.org
journal homepage: www. tctjournal. org toxification, rather than a detoxification, step. This
represents a paradigm change to traditional GSH conjugation theory. For example, DeLeve …
represents a paradigm change to traditional GSH conjugation theory. For example, DeLeve …
Autologous hematopoietic cell transplantation for myeloma patients with hepatitis B virus or hepatitis C virus in the era of novel agents
S Mizuno, A Takami, H Takamatsu… - Bone Marrow …, 2022 - nature.com
Hepatitis B virus (HBV) and hepatitis C virus (HCV) are common blood-borne infections. The
frequency of HBV reactivation in myeloma patients has increased in the era of novel agents …
frequency of HBV reactivation in myeloma patients has increased in the era of novel agents …
[HTML][HTML] Hypofibrinolysis in pediatric patients with veno-occlusive disease in hematopoietic stem cell transplantation
V Schneider, KM Cabanillas Stanchi, K Althaus… - Journal of Cancer …, 2023 - Springer
Purpose Veno-occlusive disease (VOD) is a serious complication of hematopoietic stem cell
transplantation (HSCT) with a high incidence in pediatric patients. This study aimed to detect …
transplantation (HSCT) with a high incidence in pediatric patients. This study aimed to detect …
Assessment of liver stiffness measurement and ultrasound findings change during inotuzumab ozogamicin cycles for relapsed or refractory acute lymphoblastic …
In adult patients, acute lymphoblastic leukemia (ALL) is a rare hematological cancer with a
cure rate below 50% and frequent relapses. With traditional therapies, patients with relapsed …
cure rate below 50% and frequent relapses. With traditional therapies, patients with relapsed …
Sinusoidal obstruction syndrome: a warning about autologous stem cell transplantation preceded by regimens containing oxaliplatin
PE Debureaux, DL Febvre de Nailly… - Bone Marrow …, 2020 - nature.com
Autologous stem cell transplantation (ASCT) is a cornerstone of lymphoma therapeutics,
especially in the relapse setting. BEAM (carmustine, etoposide, cytarabine, and melphalan) …
especially in the relapse setting. BEAM (carmustine, etoposide, cytarabine, and melphalan) …
Low Plasma Levels of Hyaluronic Acid Might Rule Out Sinusoidal Obstruction Syndrome after Hematopoietic Stem Cell Transplantation
C De Ramón Ortiz, R Justo Sanz, Y Beauverd… - Disease …, 2023 - Wiley Online Library
Background. Sinusoidal obstructive syndrome (SOS) is a potentially fatal complication
secondary to hematopoietic stem cell transplant (HSCT) conditioning. Endothelial damage …
secondary to hematopoietic stem cell transplant (HSCT) conditioning. Endothelial damage …